Profile
AKTS VRTX REGN VRNA ARGX ALNY
Company Name Aktis Oncology, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $996.87M $122.53B $81.62B $72.68B $50.22B $43.35B
Employees 0.00K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Matthew Roden Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
AKTS VRTX REGN VRNA ARGX ALNY
Quant Rating Score 1 4 4 1 4 3
Quant Rating Strong Sell Buy Buy Strong Sell Buy Neutral
Trading
AKTS VRTX REGN VRNA ARGX ALNY
Last Close $0.0372 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $0.11 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.04 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -66.18 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low -7 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
AKTS VRTX REGN VRNA ARGX ALNY
1 Month Return 0 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return 0 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return 0 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 0 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 0 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return -55.18 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
AKTS VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.45 % - - -
Dividend Paid and Capex Coverage Ration (TTM) 5.16 % 9.76 % 3.92 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 8.22 % - - -
Profitability
AKTS VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM 100 % 86.28 % 86.27 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -13.48 % 14.78 % 11.11 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM 65.59 % 21.81 % 14.83 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -16.93 % 19.59 % 10.3 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 86.12 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 84.5 % 111.4 % 146.19 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -3500.34 % 34.06 % 24.95 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM 122.91 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM - 6.02 2.5 1.93 1.91 3.33
Payables Turnover TTM - 0.4 2.1 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.62 0.94 2.26 6.82
Fixed Asset Turnover TTM 7.12 % 388.59 % 280.11 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 0.46 % 47.15 % 35.36 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM - 14.55 48.39 -0.85 5.67 2.02
Free Cash Flow Per Share TTM - 13.06 39.66 -0.85 5.58 1.68
Cash Per Share TTM - 2459.7 % 8362.68 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM 992.74 % 31.71 % 34.71 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 80.61 % 89.76 % 81.96 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM 122.91 % 202.64 % 184 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM 83.77 36.72 20 -995.27 127.92 195.85
Price To Operating Cash Flows Ratio TTM - 32.86 16.23 -126.33 144.41 162.25
Price Cash Flow Ratio TTM - 32.86 16.23 -126.33 144.41 162.25
Income Statement (TTM)
AKTS VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.34B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.24B $0.03B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 85.35% 93.89% 89.62% 85.62%
EBITDA $-0.05B $0.49B $5.82B $-0.12B $0.11B $-0.18B
Net Income $-0.04B $-0.54B $4.5B $-0.14B $0.83B $-0.28B
EPS Diluted - -2.08 41.48 -1.73 12.78 -2.18
Balance Sheet (MRQ)
AKTS VRTX REGN VRNA ARGX ALNY
Long Term Debt $0.01B $1.66B $2.71B $0.12B $0.03B $2.59B
Total Liabilities $0.41B $6.12B $9.3B $0.27B $0.7B $4.17B
Total Equity $-0.09B $16.41B $31.26B $0.2B $5.5B $0.07B
Total Investments $0.26B $6.65B $15.75B $0.02B $1.93B $1.73B
Total Debt $0.01B $1.75B $2.71B $0.12B $0.04B $2.74B
Total Assets $0.33B $22.53B $40.56B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
AKTS VRTX REGN VRNA ARGX ALNY
Net Income $-0.04B $-0.54B $4.5B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.28B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $-0.37B $0B $0B $0B
Operating Cash Flow $0.01B $-0.49B $4.98B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.9B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 24
AARD Aardvark Therapeutics, Inc. Common Stock 12.3411
ABCL AbCellera Biologics Inc. 3.0687
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.04
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.45
ABPWW 0.0133
ABSI Absci Corporation 2.505
ABUS Arbutus Biopharma Corporation 4.01
ABVC ABVC BioPharma, Inc. 1.65
ABVX Abivax SA American Depositary Shares 123.45
ACAD ACADIA Pharmaceuticals Inc. 22.242
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 6.876
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.21
ACIU AC Immune SA 2.97
ETFs With Exposure to AKTS
Ticker ETF Name Weight Percentage Price
IWM iShares Russell 2000 ETF 0 264.91
VTI Vanguard Total Stock Market Index Fund 0 341.79
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00012 151.54
IWN iShares Russell 2000 Value ETF 0.00145 200.6
IWV iShares Russell 3000 ETF 0.00003 393.875
IWO iShares Russell 2000 Growth ETF 0.00092 338.45
VXF Vanguard Extended Market Index Fund 0 218.35
HDG ProShares Hedge Replication ETF 0.0000833191 52.93
UWM ProShares Ultra Russell2000 0.000166344 53.81
VTHR Vanguard Russell 3000 Index Fund 0 306.12
IWC iShares Micro-Cap ETF 0.00303 166.94
URTY ProShares UltraPro Russell2000 0.0000789687 64.7
VTWG Vanguard Russell 2000 Growth Index Fund 0 247.8
VTWO Vanguard Russell 2000 Index Fund 0 107.09
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 115
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 114.98
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 52.53
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 52.52
VBINX Vanguard Balanced Index Fund Investor Shares 0 52.53
FIVG Defiance 5G Next Gen Connectivity ETF 0.23 42.32
RYLD Global X Russell 2000 Covered Call ETF 0 15.74
BMED BlackRock Future Health ETF 0.1 30.6716
DFAS Dimensional U.S. Small Cap ETF 0.00002644 76.35
DFAC Dimensional U.S. Core Equity 2 ETF 0.000146 41.36
VTSAX Vanguard Total Stock Market Index Fund 0 166.24
NTKI Nationwide Russell 2000 Risk-Managed Income ETF 0 19.0104
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 165.55
VITSX Vanguard Total Stock Market Index Fund 0 166.27
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000345953 16.69
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 165.56
SWSSX Schwab Small-Cap Index Fund-Select Shares 0.00077452 42.85
JKK iShares Morningstar Small-Cap Growth ETF 0.02 307.42
JKJ iShares Morningstar Small-Cap ETF 0.01 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0.02 65.14
TENG Direxion Daily 5G Communications Bull 2X Shares 0.171883 14.25
QWST Harbor ETF Trust - Harbor Small Cap Explorer ETF 0.1 32.0152
VEMPX Vanguard Extended Market Index InstlPlus 0 408.54
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 311.9
RSSL Global X Funds 0 103.705
Unlock